Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive

Initial data from clinical trials testing whether patients with severe coronavirus illness can be helped by a rheumatoid arthritis drug sold by Regeneron Pharmaceuticals Inc and Sanofi SA may come as early as next week, Regeneron's chief scientific officer told Reuters.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

By MICHEL ACCAD Last month marked the 400th anniversary of the birth of John Graunt, commonly regarded as the father of epidemiology.  His major published work, Natural and Political Observations Made upon the Bills of Mortality, called attention to the death statistics published weekly in London beginning in the late 16th century.  Graunt was skeptical of how causes of death were ascribed, especially in times of plagues.  Evidently, 400 years of scientific advances have done little to lessen his doubts!  A few days ago, Fox News reported that Colorado governor Jared Polis ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Medical Practice Physicians Diagnosis MICHEL ACCAD Source Type: blogs
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.” T...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Here are the facts on hydroxychloroquine, which the president has promoted to fight Covid-19 despite warnings from the F.D.A. that it can cause heart problems.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Azithromycin (Drug) Drugs (Pharmaceuticals) Preventive Medicine Research Hospitals Clinical Trials Rumors and Misinformation Rheumatoid Arthritis Lupus Erythematosus Food and Drug Adm Source Type: news
A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19). The eight patients also had a condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which is characterized by overactivation of the immune system and organ failure.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
AbstractThe coronavirus disease 2019 (COVID-19), the result of an infection with the new virus, SARS-CoV-2, is rapidly spreading worldwide. It is largely unknown whether the occurrence of COVID-19 in patients with rheumatic immune diseases has some specific manifestations, or makes them more prone to rapidly progress into severe COVID-19. In this case report, we describe the clinical features of 5 rheumatic immune disease patients with the concomitant presence of COVID-19. Amongst these patients, 4 had rheumatoid arthritis (RA) and 1 had systemic sclerosis (SSc). Two patients had a history of close contact with a COVID-19 ...
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
Dr Imran Sharief, a pulmonologist from Santa Ana California, gave tocilizumab, a drug used to treat rheumatoid arthritis, to severely ill coronavirus patients who were on ventilators.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
AbstractIn December 2019, numerous coronavirus disease 2019 (COVID-19) cases were reported in Wuhan, China, which has since spread throughout the world. However, its impact on rheumatoid arthritis (RA) patients is unknown. Herein, we report a case of COVID-19 pneumonia in a 61-year-old female RA patient who was receiving conventional disease-modifying antirheumatic drugs (cDMARDs). The patient presented with a 4-day history of myalgia and febrile sensation. COVID-19 was confirmed by real-time polymerase chain reaction (PCR). Chest X-ray showed increased opacity on the right lower lung area, and C-reactive protein level was...
Source: Rheumatology International - Category: Rheumatology Source Type: research
A small French study has found that severely ill coronavirus patients given tocilizumab, a drug used to treat rheumatoid arthritis, were less likely to be put on life support and less likely to die.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on TV. There ’s no proof they work against Covid-19.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Hydroxychloroquine (Drug) Azithromycin (Drug) Coronavirus (2019-nCoV) United States Politics and Government Autoimmune Diseases Lupus Erythematosus Rheumatoid Arthritis Trump, Donald J Food and Drug Administration Source Type: news
(Natural News) March 12 was by and large the scariest moment thus far in the life of Dr. Ryan Padgett, an emergency room doctor who probably would have died from the Wuhan coronavirus (COVID-19) were it not for an experimental regimen of integrative medicine that he was given. This date was when Dr. Padgett, who...
Source: - Category: Consumer Health News Source Type: news
More News: Arthritis | Clinical Trials | Coronavirus | COVID-19 | Health | Rheumatoid Arthritis | Rheumatology